Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yongliang Jia

Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

Frontiers in Pharmacology

Pharmacology

2019

English

The Efficacy of Guanxinning Injection in Treating Angina Pectoris: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Evidence-based Complementary and Alternative Medicine

Alternative Medicine

Complementary

2013

English

Related publications

A Novel Chromone Derivative With Anti-Inflammatory Property via Inhibition of ROS-Dependent Activation of TRAF6-ASK1-p38 Pathway

PLoS ONE

Multidisciplinary

2012

English

Anti-Cancer Effects of JKA97 Are Associated With Its Induction of Cell Apoptosis via a Bax-Dependent and P53-Independent Pathway.

Journal of Biological Chemistry

English

Pristimerin Induces Apoptosis and Autophagy via Activation of ROS/ASK1/JNK Pathway in Human Breast Cancer in Vitro and in Vivo

Cell Death Discovery

Cancer Research

Molecular Neuroscience

English

ROS/Autophagy/Nrf2 Pathway Mediated Low-Dose Radiation Induced Radio-Resistance in Human Lung Adenocarcinoma A549 Cell

International Journal of Biological Sciences

Applied Microbiology

Evolution

Ecology

Developmental Biology

English

Candidate Pathway-Based Genetic Association Study of Platinum and Platinum–taxane Related Toxicity in a Cohort of Primary Lung Cancer Patients

Journal of the Neurological Sciences

Neurology

2015

English

Sophoridine Induces Apoptosis and S Phase Arrest via ROS-dependent JNK and ERK Activation in Human Pancreatic Cancer Cells

Journal of Experimental and Clinical Cancer Research

Cancer Research

Oncology

2017

English

Oleanolic Acid Induces P53-Dependent Apoptosis via the ERK/JNK/AKT Pathway in Cancer Cell Lines in Prostatic Cancer Xenografts in Mice

Oncotarget

Oncology

2018

English

FLLL12 Induces Apoptosis in Lung Cancer Cells Through a P53/P73-Independent but Death Receptor 5-Dependent Pathway

English

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-mutant Non-Small Cell Lung Cancer Cells

Molecular Cancer Research

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yongliang Jia

Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

The Efficacy of Guanxinning Injection in Treating Angina Pectoris: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Related publications

A Novel Chromone Derivative With Anti-Inflammatory Property via Inhibition of ROS-Dependent Activation of TRAF6-ASK1-p38 Pathway

Anti-Cancer Effects of JKA97 Are Associated With Its Induction of Cell Apoptosis via a Bax-Dependent and P53-Independent Pathway.

Pristimerin Induces Apoptosis and Autophagy via Activation of ROS/ASK1/JNK Pathway in Human Breast Cancer in Vitro and in Vivo

ROS/Autophagy/Nrf2 Pathway Mediated Low-Dose Radiation Induced Radio-Resistance in Human Lung Adenocarcinoma A549 Cell

Candidate Pathway-Based Genetic Association Study of Platinum and Platinum–taxane Related Toxicity in a Cohort of Primary Lung Cancer Patients

Sophoridine Induces Apoptosis and S Phase Arrest via ROS-dependent JNK and ERK Activation in Human Pancreatic Cancer Cells

Oleanolic Acid Induces P53-Dependent Apoptosis via the ERK/JNK/AKT Pathway in Cancer Cell Lines in Prostatic Cancer Xenografts in Mice

FLLL12 Induces Apoptosis in Lung Cancer Cells Through a P53/P73-Independent but Death Receptor 5-Dependent Pathway

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-mutant Non-Small Cell Lung Cancer Cells